Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 48
Filtrar
1.
Eur J Cancer ; 40(15): 2192-200, 2004 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-15454244

RESUMO

In spite of recent advances in anti-cancer treatments, most adult cancer patients still ultimately die from their disease. There should therefore be free access to palliative care around the clock and seven days a week, for all cancer patients, as a fundamental human right. At present, the implementation of palliative care and patients' access to it are inconsistent across Europe and many other parts of the world. The World Health Organisation (WHO) made an important advance in 1986 by first defining palliative care and, then updating this definition in 2002. However, this definition could benefit from further refinement in order to reflect the increasing multi-professional specialisation in this subject, and to recognise the different models for delivering this type of care. We recommend that palliative care should be defined as follows: Palliative care is the person-centred attention to symptoms, psychological, social and existential distress in patients with limited prognosis, in order to optimise the quality of life of patients and their families or close friends. Based on this definition, we propose two further types of palliative care which reflect the reality of how palliative care is actually delivered: Basic palliative care is the standard of palliative care which should be provided by all healthcare professionals, in primary or secondary care, within their normal duties to patients with life-limiting disease. Specialised palliative care is a higher standard of palliative care provided at the expert level, by a trained multi-professional team, who must continually update their skills and knowledge, in order to manage persisting and more complex problems and to provide specialised educational and practical resources to other non-specialised members of the primary or secondary care teams. If a patient has difficult symptoms which cannot be controlled by his/her current healthcare team, he/she has a right to be referred, and the current healthcare provider has an obligation to refer, to the local palliative care team. Important priorities to ensure the standardisation of, and uniform access to, palliative care for all cancer patients include: Integration of palliative care services with the primary care and oncology teams. Establishment of a specialised palliative care service in each major cancer centre. Establishment of educational programmes covering palliative care for undergraduates, oncologists, primary care team members and specialists training in palliative care. Support for research using appropriate methodologies to underpin the scientific basis of palliative care. Establishment of quality assurance programmes. Recognition of palliative medicine as a medical specialty. Establishment of academic centres of excellence with chairs of palliative medicine and palliative care nursing. Removal of unnecessary restrictions on all drugs which are proven to be of benefit in symptom control, especially improving access to strong opioids. Improved information for patients and family carers to allow them to make choices and exercise autonomy.


Assuntos
Neoplasias/terapia , Cuidados Paliativos/métodos , Humanos , Cooperação Internacional , Cuidados Paliativos/normas
2.
Med Clin (Barc) ; 101(12): 446-9, 1993 Oct 16.
Artigo em Espanhol | MEDLINE | ID: mdl-7694015

RESUMO

BACKGROUND: It is currently believed that the home is not the most adequate place to die. Ninety percent of the deaths happen in hospitals. The home care of terminally ill cases by a palliative care team is analyzed. METHODS: In 93 (53 males and 40 females, mean age 63 years, range 31-89 years) oncologic patients followed at home until death the number of visits and their length, the most important symptoms, the length of the terminal phase and the place of death were analyzed. RESULTS: Two hundred fifteen visits were carried out. The length per visit per patient was of 40 minutes. The terminal phase oscillated between 1 and 425 days with a median of 50 days. Pain and dyspnea were the most important symptoms. Death occurred at home in fifty-three (59%) patients and in the hospital in 37 (41%). The median survival from diagnosis was 10 months. CONCLUSIONS: Home care increase the percentage of deaths in the home if adequate alleviation of symptoms, permanent communication and constant family support are provided.


Assuntos
Serviços de Assistência Domiciliar , Cuidados Paliativos , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Serviços de Assistência Domiciliar/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/mortalidade , Neoplasias/terapia , Cuidados Paliativos/estatística & dados numéricos , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Espanha/epidemiologia , Análise de Sobrevida , Assistência Terminal/estatística & dados numéricos , Fatores de Tempo
3.
Med Clin (Barc) ; 97(9): 340-1, 1991 Sep 21.
Artigo em Espanhol | MEDLINE | ID: mdl-1720492

RESUMO

A case of post-chemotherapy gynecomastia is reported in a 40 years old male patient with a tumor of seminomatous germinal cells with no evidence of tumoral reappearance or augmentation of the chorionic gonadotropin hormone. The existence of primary hypogonadism was tested. A differential diagnosis was performed and possible physiopathological mechanisms of the gynecomastia were analyzed in a patient previously treated for testicular cancer.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Disgerminoma/tratamento farmacológico , Ginecomastia/induzido quimicamente , Neoplasias Testiculares/tratamento farmacológico , Adulto , Bleomicina/efeitos adversos , Cisplatino/efeitos adversos , Humanos , Masculino , Fatores de Tempo , Vimblastina/efeitos adversos
4.
Eur J Pain ; 16(3): 381-9, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22337158

RESUMO

BACKGROUND: Despite effective analgesic therapy, inadequate pain control is frequently perceived by patients and caregivers. AIMS: To assess satisfaction with management of pain in cancer patients. METHODS: Between January and May 2007, a cross-sectional multicentre study was conducted in 64 Medical Oncology Departments throughout Spain. A total of 525 outpatients with oncological diseases completed a questionnaire with demographic data, characteristics and intensity of pain, and perceptions and attitudes towards pain management at the time of a routine clinical visit. Physicians also completed a questionnaire with tumour-related and treatment-related data. Cluster analysis was used to classify patients into three groups (satisfied, neither satisfied nor dissatisfied or neutral, dissatisfied) according to pain intensity and satisfaction with treatment. RESULTS: Patients satisfied with their analgesic treatment (33%) had lower pain intensities and, when regularly asked about their pain, considered their physicians to be more involved in their treatment. Neither satisfied nor dissatisfied patients (neutral) (44%) had higher mean pain intensities. Two-thirds of them achieved marked relief of their pain and also thought that physicians were aware of their situation. Dissatisfied patients (23%) had moderate to severe pain intensities, and said that they were asked less frequently about their pain, and thought that their physicians were less involved in their analgesic treatment. CONCLUSION: Physician-patient communication and information provided to patients are essential aspects of patient perceptions and attitudes towards control of cancer-related pain. Pain is seen as a condition that may be controlled but affects the capacity to lead a normal life.


Assuntos
Analgésicos/uso terapêutico , Neoplasias/complicações , Dor/tratamento farmacológico , Satisfação do Paciente , Idoso , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Dor/etiologia , Medição da Dor , Relações Médico-Paciente , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA